The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| HYPMY | -8.73% | -6.8% | -1.4% | -60% |
| S&P | +16.23% | +94.45% | +14.22% | +511% |
Hypera SA is a pharmaceutical company, which engages in the manufacture and distribution of medical and cosmetics products. Its products include foods and sweeteners; over-the-counter medication; prescribed medication; and dermocosmetics. The company was founded on December 1, 2001 and is headquartered in Sao Paulo, Brazil.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $380.09M | -9.5% |
| Gross Profit | $219.99M | -11.2% |
| Gross Margin | 57.88% | -1.1% |
| Market Cap | $3.05B | -6.0% |
| Net Income | $75.19M | -20.3% |
| EBITDA | $124.59M | -9.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $220.53M | -56.8% |
| Accounts Receivable | $290.94M | -48.0% |
| Inventory | 386.3 | 11.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.36B | -10.2% |
| Short Term Debt | $295.84M | -15.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 2.63% | -3.8% |
| Return On Invested Capital | 8.95% | -0.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$16.05M | -162.8% |
| Operating Free Cash Flow | $11.61M | -72.2% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 10.06 | 7.26 | 14.01 | 23.79 | 144.63% |
| Price to Book | 1.42 | 0.86 | 1.09 | 1.49 | 7.29% |
| Price to Sales | 2.04 | 1.36 | 1.76 | 2.72 | 31.57% |
| Price to Tangible Book Value | 41.31 | 19.47 | 43.06 | -208.48 | -350.88% |
| Price to Free Cash Flow TTM | 17.45 | 75.98 | 45.90 | 589.67 | 2791.83% |
| Enterprise Value to EBITDA | 47.33 | 141.70 | -154.75 | 37.10 | 8.90% |
| Free Cash Flow Yield | 5.7% | 1.3% | 2.2% | 0.2% | -96.54% |
| Return on Equity | 13.4% | 11.8% | 6.9% | 6.1% | -59.73% |
| Total Debt | $1.92B | $1.55B | $1.66B | $1.66B | -11.30% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
